J. E. Davis - 12 Feb 2025 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Reporting owner
Role
CEO and President, Director
Signature
Sean D. Mersten, Attorney in Fact for James E. Davis
Issuer context
Issuer symbol
DGX
Transaction snapshot
Transactions as of
12 Feb 2025
Net transaction value
$0
SEC evidence
Form type
4
Filing time
14 Feb 2025, 17:30:28 UTC
Previous filing
01 Mar 2024
Next filing
21 Feb 2025
SEC filing
View on sec.gov

Key filing fact

J. E. Davis filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 14 Feb 2025.

Key facts

  • This page summarizes J. E. Davis's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
  • 2 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 14 Feb 2025, 17:30.

Change

  • Previous filing in this sequence was filed on 01 Mar 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

DGX transaction

Common Stock

Award

Transaction value
$0
Shares
+18,149
Change %
+14%
Price
$0.000000
Shares after
144,117
Date
12 Feb 2025
Ownership
Direct
Footnotes
F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

DGX transaction Derivative

Non-Qualifed Stock Option (right to buy)

Award

Transaction value
$0
Shares
+69,633
Change %
Price
$0.000000
Shares after
69,633
Date
12 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
69,633
Exercise price
$165.30
Footnotes
F2
* indicates a reported price that failed the local validity check.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units.
F2 The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .